Literature DB >> 11986257

Use of immunoglobulin m cross-reactions in differential diagnosis of human flaviviral encephalitis infections in the United States.

Denise A Martin1, Brad J Biggerstaff, Becky Allen, Alison J Johnson, Robert S Lanciotti, John T Roehrig.   

Abstract

To define the virus specificity of the immunoglobulin M (IgM) antibody-capture enzyme-linked immunosorbent assay (MAC-ELISA) among the medically important members of the Japanese encephalitis (JE) virus serocomplex of flaviviruses, 103 IgM-positive human serum samples from patients with confirmed West Nile (WN) virus, St. Louis encephalitis (SLE) virus, or JE virus infections were assembled and simultaneously tested against all three viral antigens in a standardized MAC-ELISA. Of the serum samples tested, 96 (93%) showed higher positive-to-negative absorbance ratios (P/Ns) with the infecting virus antigen compared to those obtained with the other two virus antigens. Of the seven specimens with higher P/Ns with heterologous virus antigens, six were from patients with SLE virus infections (the serum samples had higher levels of reactivity with WN virus antigen) and one was from a patient with a JE virus infection (this serum sample also had a higher level of reactivity with WN virus antigen). Not surprisingly, similar virus specificity was observed with WN virus-elicited IgM in cerebrospinal fluid. As shown in previous studies, a subset of these specimens was even less reactive in the MAC-ELISA with dengue virus, a member of a different flavivirus serocomplex. The degree of virus cross-reactivity did not appear to be related to days postonset, at least during the first 40 days of infection. Infections with WN virus could be correctly distinguished from infections with SLE virus on the basis of the observed anti-viral IgM cross-reactivities alone 92% of the time. Infections with SLE virus resulted in antibody that was more cross-reactive, so identification of SLE virus as the infecting agent by use of MAC-ELISA cross-reactivity alone was more problematic.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11986257      PMCID: PMC120001          DOI: 10.1128/cdli.9.3.544-549.2002

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  11 in total

1.  Detection of West Nile virus sequences in cerebrospinal fluid.

Authors:  T Briese; W G Glass; W I Lipkin
Journal:  Lancet       Date:  2000-05-06       Impact factor: 79.321

2.  Evaluation of immunoglobulin M (IgM) and IgG enzyme immunoassays in serologic diagnosis of West Nile Virus infection.

Authors:  G Tardei; S Ruta; V Chitu; C Rossi; T F Tsai; C Cernescu
Journal:  J Clin Microbiol       Date:  2000-06       Impact factor: 5.948

3.  Bootstrap confidence intervals for the sensitivity of a quantitative diagnostic test.

Authors:  R W Platt; J A Hanley; H Yang
Journal:  Stat Med       Date:  2000-02-15       Impact factor: 2.373

4.  Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1997-05-02

5.  Primer on certain elements of medical decision making.

Authors:  B J McNeil; E Keller; S J Adelstein
Journal:  N Engl J Med       Date:  1975-07-31       Impact factor: 91.245

6.  Standardization of immunoglobulin M capture enzyme-linked immunosorbent assays for routine diagnosis of arboviral infections.

Authors:  D A Martin; D A Muth; T Brown; A J Johnson; N Karabatsos; J T Roehrig
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

7.  Japanese encephalitis among hospitalized pediatric and adult patients with acute encephalitis syndrome in Hanoi, Vietnam 1995.

Authors:  P W Lowry; D H Truong; L D Hinh; J L Ladinsky; N Karabatsos; C B Cropp; D Martin; D J Gubler
Journal:  Am J Trop Med Hyg       Date:  1998-03       Impact factor: 2.345

8.  Origin of the West Nile virus responsible for an outbreak of encephalitis in the northeastern United States.

Authors:  R S Lanciotti; J T Roehrig; V Deubel; J Smith; M Parker; K Steele; B Crise; K E Volpe; M B Crabtree; J H Scherret; R A Hall; J S MacKenzie; C B Cropp; B Panigrahy; E Ostlund; B Schmitt; M Malkinson; C Banet; J Weissman; N Komar; H M Savage; W Stone; T McNamara; D J Gubler
Journal:  Science       Date:  1999-12-17       Impact factor: 47.728

9.  Detection of Japanese encephalitis virus immunoglobulin M antibodies in serum by antibody capture radioimmunoassay.

Authors:  D S Burke; A Nisalak
Journal:  J Clin Microbiol       Date:  1982-03       Impact factor: 5.948

10.  West Nile virus activity--United States, September 12-18, 2002, and Ohio, January 1-September 12, 2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-09-20       Impact factor: 17.586

View more
  63 in total

Review 1.  West Nile encephalitis.

Authors:  Tom Solomon; Mong How Ooi; David W C Beasley; Macpherson Mallewa
Journal:  BMJ       Date:  2003-04-19

Review 2.  Current advances in dengue diagnosis.

Authors:  Pei-Yun Shu; Jyh-Hsiung Huang
Journal:  Clin Diagn Lab Immunol       Date:  2004-07

3.  Evaluation of three commercially available Japanese encephalitis virus IgM enzyme-linked immunosorbent assays.

Authors:  Jaimie S Robinson; David Featherstone; Ravi Vasanthapuram; Brad J Biggerstaff; Anita Desai; Nalini Ramamurty; Anwarul Haque Chowdhury; Hardeep S Sandhu; Kathleen F Cavallaro; Barbara W Johnson
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

Review 4.  Neurologic aspects of infections in international travelers.

Authors:  May H Han; Joseph R Zunt
Journal:  Neurologist       Date:  2005-01       Impact factor: 1.398

5.  Molecular typing of West Nile Virus, Dengue, and St. Louis encephalitis using multiplex sequencing.

Authors:  Thuraiayah Vinayagamoorthy; Kirk Mulatz; Michael Drebot; Roger Hodkinson
Journal:  J Mol Diagn       Date:  2005-05       Impact factor: 5.568

6.  Differentiation of West Nile and St. Louis encephalitis virus infections by use of noninfectious virus-like particles with reduced cross-reactivity.

Authors:  Jill A Roberson; Wayne D Crill; Gwong-Jen J Chang
Journal:  J Clin Microbiol       Date:  2007-08-22       Impact factor: 5.948

7.  Development of immunoglobulin M capture enzyme-linked immunosorbent assay to differentiate human flavivirus infections occurring in Australia.

Authors:  Carmel Taylor; Russell Simmons; Ina Smith
Journal:  Clin Diagn Lab Immunol       Date:  2005-03

8.  Detection of anti-West Nile virus immunoglobulin M in chicken serum by an enzyme-linked immunosorbent assay.

Authors:  Alison J Johnson; Stanley Langevin; Katherine L Wolff; Nicholas Komar
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

Review 9.  Diagnostic Approach for Arboviral Infections in the United States.

Authors:  Anne Piantadosi; Sanjat Kanjilal
Journal:  J Clin Microbiol       Date:  2020-11-18       Impact factor: 5.948

10.  Enzyme-linked immunosorbent assays using recombinant envelope protein expressed in COS-1 and Drosophila S2 cells for detection of West Nile virus immunoglobulin M in serum or cerebrospinal fluid.

Authors:  A Scott Muerhoff; George J Dawson; Bruce Dille; Robin Gutierrez; Thomas P Leary; Malini C Gupta; Charles R Kyrk; Hema Kapoor; Patricia Clark; Gerald Schochetman; Suresh M Desai
Journal:  Clin Diagn Lab Immunol       Date:  2004-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.